-
Study aim
-
1- Determine the effect of metoclopramide injection before NG-Tube on the severity of pain caused by NG-Tube.
2- Determine the effect of metoclopramide injections before NG-Tube injection on patient discomfort
3. Determine the effect of metoclopramide injection before NG-Tube on the incidence of NG-Tube nausea and vomiting.
-
Design
-
A randomized, controlled, double-blind, placebo-controlled clinical trial
-
Settings and conduct
-
The study is performed in the hospital emergency department and in patients who require NG tube. Patients were randomly divided into case (metoclopramide) and control (placebo) groups.
The project associate will label the syringes without the knowledge of the researcher, physician, nurse, and patient evaluator, and all NG tube insertions will be performed by a person who is unaware of the placement of the patients into two groups. The degree of discomfort as well as the severity of pain and nausea will be assessed immediately and 30 and 60 minutes after the procedure using the VAS criteria in the two groups.
-
Participants/Inclusion and exclusion criteria
-
Patients with an indication of NG tube and over 18 years old who are willing to participate in the study are included.
patients with unconsciousness, pregnancy, unstable hemodynamic status, nasal bleeding at study time, nasal anatomical problems, sensitivity to metoclopramide, use of metoclopramide interfering drugs, patients presenting with nausea and vomiting, trauma patients and patients have more than twice attempted a NGT insertion Yard is not included in the study.
-
Intervention groups
-
For the case group, 10 mg metoclopramide will be administered intravenously 15 minutes before the procedure, and for the control group, the same volume of normal saline will be administered.
-
Main outcome variables
-
Discomfort; severity of pain; nausea